Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act (H.R. 2891/S. 1323) and the Secure and Fair Enforcement Regulation (SAFER) Banking Act (S. 2860).
Duration: March 6, 2019
to
present
General Issues: Banking , Government Issues , Law Enforcement/Crime/Criminal Justice , Medical/Disease Research/Clinical Labs , Taxation/Internal Revenue Code
Spending: about $1,810,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: House of Representatives, U.S. Senate, White House Office, Natl Economic Council (NEC), Treasury - Dept of
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Bret Boyles Staff Assistant, Deputy Chief of Staff, Chief of Staff, Sen.Lott, 1996-97, 2005-07
Natasha Hammond Oct. 2015-Nov 2015: Assist. for Policy to the Speaker Rep. Paul Ryan; Sep. 2006-Oct. 2015: Asst. for Policy, Speaker John Boehner; Legis. Dir., Legis. Asst, Legis. Correspondent; SA, Intern, Rep. John Boehner.
Austin Harrison March 2009: Intern for Cong. Gregg Harper;
May-Aug. 2013: Intern for Sen. Thad Cochran; January-May 2015: June-August 2015: U.S. Department of State, intern, U.S. Embassy, Zagreb, Croatia.
David Schnittger Dep. Chief of Staff, Speaker Boehner, 2006-2015; Press Secr., Rep. John Boehner 1994-2001; Communications Director, House Committee on Education and the Workforce 2001-2005
Lem Smith IV 2001-2004, Legislative Director, Rep Charlie Norwood; 1999-2001, Legislative Assistant, Rep. Roger Wicker; 1998-1999, Staff Assistant, Senate Majority Leader Trent Lott
Mara Sheldon 1995-1996-Press Sec to Cong. Peter Deutsch; 1996-1997-Com. Dir. to Cong. John D. Dingell; 1997-1998-Com. Dir. to Cong. Brad Sherman; 2000-Com. Dir. to Cong. Nydia Velazquez and to Com. on Small Business.
Thomas Andrews 2009-2013:SA/LC and Sr SA, Rep. John Boehner; 2013-2015:SA to Speaker John Boehner; 2015-2018: Dir of Member Services, Speaker Paul Ryan; 2018- 2021: SA to President for Leg Affairs, White House
Rebekah Sungala Jan. 2018 - Jan. 2019: Leg. Assist., House Transportation & Infrastructure Committee; Sept. 2017-Jan. 2019: Scheduler/Executive Assistant; Congressman Bill Shuster; Nov. 2012-Aug. 2017: Sr. Field Rep., Congressman Bill Shuster
John Criscuolo Jr. n/a
Caffey Norman n/a
Jeff Turner n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $50,000. The report was filed on April 5.
Original Filing: 301546783.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act (H.R. 2891/S. 1323) and the Secure and Fair Enforcement Regulation (SAFER) Banking Act (S. 2860).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $70,000. The report was filed on Jan. 15.
Original Filing: 301524564.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $60,000. The report was filed on Oct. 9, 2023.
Original Filing: 301498549.xml
Lobbying Issues
Advocacy in support of the enactment of the Secure and Fair Enforcement (SAFE) Act to reform federal law and policy governing financial transactions applicable to cannabis.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on July 12, 2023.
Original Filing: 301475068.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Government Issues/Disease Research/Clinical Labs
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Harnessing Opportunities by Pursuing Expungement Act (H.R. 6129).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2023
In Q1, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on April 11, 2023.
Original Filing: 301450435.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Harnessing Opportunities by Pursuing Expungement Act (H.R. 6129).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on Jan. 17, 2023.
Original Filing: 301428858.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Government Issues/Disease Research/Clinical Labs
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Harnessing Opportunities by Pursuing Expungement Act (H.R. 6129).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2022
In Q3, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on Oct. 11, 2022.
Original Filing: 301402750.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Harnessing Opportunities by Pursuing Expungement Act (H.R. 6129).
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2022
In Q2, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on July 11, 2022.
Original Filing: 301378793.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on April 13, 2022.
Original Filing: 301345633.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Harnessing Opportunities by Pursuing Expungement Act (H.R. 6129).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2021
In Q4, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $100,000. The report was filed on Jan. 19, 2022.
Original Filing: 301327555.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Government Issues/Disease Research/Clinical Labs
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Harnessing Opportunities by Pursuing Expungement Act (H.R. 6129).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2021
In Q3, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on Oct. 18, 2021.
Original Filing: 301301933.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act and the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Government Issues/Crime/Criminal Justice/Disease Research/Clinical Labs
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2021
In Q2, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on July 19, 2021.
Original Filing: 301281212.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act and the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2021
In Q1, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on April 19, 2021.
Original Filing: 301258286.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 2093 and S. 1028, the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2020
In Q4, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233321.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 2093 and S. 1028, the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2020
In Q3, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on Oct. 14, 2020.
Original Filing: 301209432.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 2093 and S. 1028, the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2020
In Q2, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $80,000. The report was filed on July 10, 2020.
Original Filing: 301186602.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 2093 and S. 1028, the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2020
In Q1, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $120,000. The report was filed on April 7, 2020.
Original Filing: 301154388.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 2093 and S. 1028, the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Correcting flaws in the US tax codethat serve as barriers to legal commerce in the cannabis industry.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2019
In Q4, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $150,000. The report was filed on Jan. 16, 2020.
Original Filing: 301107481.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Squire Patton Boggs lobbied for National Cannabis Roundtable , earning $150,000. The report was filed on Oct. 17, 2019.
Original Filing: 301067656.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
Squire Patton Boggs amended a lobbying report for representation of National Cannabis Roundtable in Q22019 on July 25, 2019.
Original Filing: 301060002.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 1595 and S. 1200, the Secure and Fair Enforcement (SAFE) Banking Act of 2019.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including H.R. 2093 and S. 1028, the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2019
In Q1, Squire Patton Boggs lobbied for National Cannabis Roundtable . The report was filed on April 18, 2019.
Original Filing: 301029372.xml
Lobbying Issues
Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Banking/Disease Research/Clinical Labs
1st Quarter, 2019
Squire Patton Boggs filed a lobbying registration on March 15, 2019 to represent National Cannabis Roundtable, effective March 6, 2019.
Original Filing: 301021574.xml
Issue(s) they said they’d lobby about: Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...